MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

10 Aug 2022 Evaluate
A decrease in the sales to Rs. 629.37 millions was observed for the quarter ended June 2022. The sales stood at Rs. 759.09 millions during the similar quarter previous year.Net Profit for the quarter ended June 2022 dipped to Rs. 5.12  millions from Rs. 193.49 millions  in the corresponding previous quarter.A decline of 31.23 millions was observed in the OP in the quarter ended June 2022 from 280.49 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 629.37 759.09 -17.09 629.37 759.09 -17.09 3186.67 2552.07 24.87
Other Income 36.47 49.22 -25.90 36.47 49.22 -25.90 126.40 115.21 9.71
PBIDT 31.23 280.49 -88.87 31.23 280.49 -88.87 782.09 852.30 -8.24
Interest 4.98 3.70 34.59 4.98 3.70 34.59 15.62 18.40 -15.11
PBDT 26.25 276.79 -90.52 26.25 276.79 -90.52 766.47 833.90 -8.09
Depreciation 19.58 19.33 1.29 19.58 19.33 1.29 76.73 73.94 3.77
PBT 6.67 257.46 -97.41 6.67 257.46 -97.41 689.74 759.96 -9.24
TAX 1.55 63.97 -97.58 1.55 63.97 -97.58 167.28 205.28 -18.51
Deferred Tax -7.20 3.97 -281.36 -7.20 3.97 -281.36 -4.22 14.58 -128.94
PAT 5.12 193.49 -97.35 5.12 193.49 -97.35 522.46 554.68 -5.81
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 4.96 36.95 -86.57 4.96 36.95 -86.57 24.54 33.40 -26.51
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..